Morfina taldea - Euskara

262
Doktore-tesia
Bibliografia
Ortega-Alvaro A, Chover-González AJ, Lai-Kuen R, Mico JA, Giber-Rahola J,
Fournié-Zaluski MC, Roques BP, Maldonado R. Antinociception produced by the peptidase
inhibitor, RB101, in rats with adrenal medullary transplant into the spinal cord. Eur J Pharmacol.
356: 139-148. 1998.
Ozaita A, Escribá PV, Vebtanyol P, Murga C, Mayor F, García-Sevilla JA. Regulation
of G-protein coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. 70:
1249-1257. 1998.
Paik SH, Camarao GC, Bauer JA, Leite PE, Oliveira ES, Camargo AC, Farges RC.
Effects of morphine withdrawal syndrome on endo-oligopeptidase (EC 3.4.22.19) activity. Eur J
Pharmacol. 253: 101-106. 1994.
Palczewski K, Benovic JL. G-protein coupled receptor kinases. Rends Biochem Sci. 16: 387-
391. 1991.
Pasternak GW. Múltiple morphine and enkephalin receptors: Biochemical and pharmacological
aspects. Ann. NY. Acad. Sci. 467: 130-139.
Peckys D, Landwehrmeyer GB. Expression of mu, kappa, and delta opioid receptor
messenger RNA in the human CNS: a 33P in situ hybridization study. Neuroscience. 88(4):
1093-1135. 1999.
Pert C, Pert A, Chang JK, Fong BTW. [D-Ala2-] – Met-enkephalinamide: A potent, longlasting
synthetic pentapeptide analgesic. Science. 194: 330332. 1976.
Pert C, Snyder S. Opiate receptor; demonstration in nervous tissue. Science. 179: 1011-1014.
1973.
Pilapil C, Welner, Magnan J, Gauthier S, Quirino R. Autoradigraphic distribution of
multiple classes of opioid receptor binding sites in human forebrain. Brain. Res. Bull. 19: 611-615.
1987.